Summary
Recent published evidences on ibuprofen and meloxicam confirm the need of faster oral drug absorption to overcome the pathophysiological conditions associated with dental pain (due to excessive vagal nerve suppression) in order to provide relief in acute pain management. While the communication provides relevant case studies to support the hypothesis in both dental pain and migraine attacks, it also provides biopharmaceutical and pharmacokinetic challenges of developing such a strategy for faster oral drug absorption. It is envisaged that the unmet need in this area, to overcome the pathophsiological barriers, should provide impetus for further research exploration in formulation strategies and biopharmaceutical /pharmacokinetic integration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Delco F., Tchambaz L., Schlienger R., Drewe J., Krahenbuhl S. (2005): Dose adjustment in patients with liver disease. Drug Saf., 28, 529–545.
Gomez C.M.H., Cordingly J.J., Palazzo M.G.A. (1999): Altered Pharmacokinetics of Ceftazidime in Critically Ill Patients. Antimicrob. Agents Chemother., 43, 1798–1802.
Jamali F., Kunz-Dober C.M. (1999): Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery. Br. J. Clin. Phannacol., 47, 39 1–396.
Hersh E.V., Levin L.M, Cooper S.A., Doyle G., Waksman J., Wedell D., Hong D., Secreto S.A. (2000): Ibuprofen liquigel for oral surgery pain. Clin. Ther., 22, 306–1318.
Jamali F., Aghazadeh-Habashi A. (2008): Rapidly dissolving formulations for quick absorption during pain episodes: Ibuprofen. Int. J. Clin. Pharmacol. Ther., 46, 55–63.
Aghazadeh-Habashi A., Jamali F. (2008): Pharrnacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: Influence of gastrointestinal dysfunction on the relative bioavailability of two formulations. Eur. J. Pharm. Biopharm., 70, 889–894.
Hersh E.V., Levin L.M., Adamson D., Christensen S., Kiersch T.A., Noveck R., Watson G. 2nd., Lyon J.A. (2004): Doseranging analgesic study of prosorb diclofenac potassium in postsurgical dental pain. Clin. Ther., 26, 1215–1227.
Berthold C.W., Dionne R.A., Corey S.E. (1997): Comparison of sublingually and orally administered triazolam for premedication before oral surgery. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 84, 119–124.
Attia M.A., El-Gibaly I., Shaltout S.E., Fetih G.N. (2004): Transbuccal permeation, antiinflammatory activity and clinical efficacy of piroxicam formulated in different gels. Int. J. Pharm., 276, 11–28.
Alsarra l.A., Alanazi F.K., Mahrous G.M., Abdel Rahman A.A. Al Hezaimi K.A. (2007): Clinical evaluation of novel buccoadhesive film containing ketorolac in dental and postoral surgery pain management. Pharmazie, 62, 773–778.
Maas H.J., Spruit M.A., Danhof M., Della Pasqua O.E. (2008) Relevance of absorption rate and lag time to the onset of action in migraine. Clin. Pharmacokinet., 47, 139–146.
Ferrari A., Pinetti D., Bertolini A., Coccia C., Sternieri E. (2008): Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients. Eur. J. Clin. Pharmacol., 64, 489–495.
Barbanti P., Le Pera D., Cruccu G. (2007): Sumatriptan fast-disintegrating/rapid-release tablets in the acute treatment of migraine. Expert Rev. Neurother., 7, 927–934.
Marcilio S.S., Cunha F., Martinez-Pacheco R., Landin M. (2008): Dissolution rate enhancement of the novel antitumoral β-lapachone by solvent change precipitation of microparticles. Eur. J. Phann.. Biopharm., 69, 871–877.
Saadia A., Tayel Soliman II, Louis D. (2008): Improvement of dissolution properties of carbamazepine through application of the liquisolid tablet technique. Eur. J. Pharm. Biopharm., 69, 342–347.
Patel D., Shah M., Shah S., Shah T., Amin A. (2008): Design, development, and optimization of orally disintegrating tablets of etoricoxib using vacuum-drying approach. PDA J. Pharm. Sci. Technol., 62, 224–232.
Whitehead K., Mitragotri S. (2008): Mechanistic analysis of chemical permeation enhancers for oral drug delivery. Pharm. Res., 25, 1412–1419.
Whitehead K., Karr N., Mitragotri S. (2008): Safe and effective permeation enhancers for oral drug delivery. Pharm. Res., 25, 1782–1788.
Schleier P., Prochnau A., Schmidt-Westhausen A.M., Peters H., Becker J., Latz T., Jackowski J., Peters E.U., Romanos G.E., Zahn B., Ludemann J., Maares J., Petersen B. (2007): Ibuprofen sodium dihydrate, an ibuprofen formulation with improved absorption characteristics, provides faster and greater pain relief than ibuprofen acid. Tnt. J. Clin. Pharmacol. Ther., 45, 89–97.
Inamdar N., Bhise K., Memon S. (2008): Solubility enhancement and development of dispersible tablet of meloxicam. Asian J. Pharm., 2, 128–132.
Ahmed I.S., Fatahalla F.A. (2007): Pilot study of relative bioavailability of two formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet. Drug Dev. Ind. Pharm., 33, 505–511.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Srinivas, N.R. Rationale for faster oral delivery to overcome the pathophysiology associated with dental pain — Biopharmaceutic and pharmacokinetic challenges. Eur. J. Drug Metabol. Pharmacokinet. 34, 7–10 (2009). https://doi.org/10.1007/BF03191377
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03191377